Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032 ...Middle East

SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), today announced the pricing of $650 million aggregate principal amount of 0% convertible senior notes due 2031 (the "2031 Notes") and $650 million aggregate principal amount...

Hence then, the article about halozyme therapeutics inc announces pricing of private offering of 650 million of convertible senior notes due 2031 and 650 million of convertible senior notes due 2032 was published today ( Friday 07/11/2025 - 07:52 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032 )

Also on site :

• Finn Wolfhard's 'Stranger Things' SNL Skit Met With Backlash From Fans
• Who Is Katie Bates’ Husband Travis Clark? What We Know About the Affair Admission
• Derek Hough Teases Something Special Involving His ‘Beautiful Daughter’